Significance in Preventative Medicine

09.09.13 | By

Innovative research and development has led to revolutionary medical treatments and practices that have impacted how we think about preventative medicine. While colloquialisms like “an apple a day keeps the doctor away” still hold true, thanks to hardworking researchers, academics and individuals throughout the health care ecosystem, we now have an increasing selection of cutting-edge treatments that can protect us from some of the most debilitating diseases.

Prostate Cancer and Ovarian Cancer Awareness Month

09.05.13 | By

With the start of school and everyone resuming their normal routine, now is the time to schedule your regular doctor’s visit. Given the craziness of summer, health is often an afterthought -- but now is the time to make it a priority.

Finalizing the Agreement

08.30.13 | By

The 19th round of Trans-Pacific Partnership (TPP) negotiations in Brunei conclude today, and with countries looking to finalize the agreement by the end of this year, there is much to be done in the coming months.  

New Treatments for Patients

08.30.13 | By

Making a new treatment available to patients takes more than a decade and a billion dollars. Given the time and resources it takes to successfully bring a drug to market, the need for strong intellectual property (IP) protections in the U.S. and abroad has never been more important.

Kristin Van Goor

Kristin Van Goor is a Senior Director of Scientific and Regulatory Affairs at PhRMA.  She leads PhRMA’s activities on regulatory and science policy issues ranging from innovative biologics and biosimilars, information technology, benefit-risk assessment, and patient-focused drug development.  Kristin is a geneticist by training, having received her doctorate from Yale University and completing a postdoctoral fellowship in the Cancer Genetics Branch of the National Human Genome

PhRMA Conversations

08.29.13 | By

As we’ve previously noted on the Catalyst, medication adherence continues to be a serious challenge with significant consequences to patient health and costs associated with acute care, hospitalizations and surgery. Today, nearly 145 million Americans suffer from chronic disease, but only one-third take their medications as prescribed.

Partnership for Safe Medicines India Initiative Hosts National Multi-Stakeholder Forums to Help Protect Patients

08.28.13 | By

Across the globe, millions of patients are put at risk by counterfeit, substandard or otherwise unsafe medicines. As Executive Director of the Partnership for Safe Medicines in the United States, I traveled to India this week to participate in two national workshops hosted by the PSM India Initiative, an organization working to raise awareness and empower consumers across the country.

Clinical Trials in South Carolina

08.28.13 | By

At a time when there is growing concern about diversity in clinical trials, we learned yesterday that 26 percent of people who participate in treatment trials at the Medical University of South Carolina's Hollings Cancer Center (HCC) are African American.

Dr. Marvella E. Ford, HCC's associate director, cancer disparities, attributes that success to the center's comprehensive clinical trials education program at 17 facilities in 11 South Carolina counties.

PhRMA Foundation

08.27.13 | By

The PhRMA Foundation is seeking applications for its Young Investigator Center for Adherence Improvement Award. The award will provide stipend support for individuals who are doing research that will advance and improve medication adherence.

PhRMA Conversations - Clinical Trials Data Sharing and Patient Privacy

08.27.13 | By

Last month, PhRMA and the European Federation of Pharmaceutical Industries and Associations (EFPIA) endorsed joint Principles for Responsible Clinical Trial Data Sharing: Our Commitment to Patients and Researchers.

Pages

Subscribe to RSS - Opinion